Hemab Therapeutics Holdings, Inc. (COAG) Net margin
Hemab Therapeutics Holdings, Inc. (COAG) net profit margin by fiscal year — reported net income divided by reported revenue.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to COAGSource: SEC XBRL filings · For reference only · Not investment advice
More COAG financial trends
COAG RevenueCOAG Net incomeCOAG Gross profitCOAG Gross marginCOAG Operating incomeCOAG Operating marginCOAG Operating cash flowCOAG Free cash flowCOAG Capital expendituresCOAG Return on equityCOAG Stock buybacksCOAG Dividends paidCOAG Total assetsCOAG Total liabilitiesCOAG Shareholders’ equityCOAG overview →